p63 Inhibits Extravillous Trophoblast Migration and Maintains Cells in a Cytotrophoblast Stem Cell-Like State  by Li, Yingchun et al.
The American Journal of Pathology, Vol. 184, No. 12, December 2014
AS
IP
20
14
AJ
P
CM
E P
rog
ramMETABOLIC, ENDOCRINE, AND GENITOURINARY PATHOBIOLOGY
p63 Inhibits Extravillous Trophoblast Migration and
Maintains Cells in a Cytotrophoblast Stem Cell-Like State
Yingchun Li,*y Matteo Moretto-Zita,*y Sandra Leon-Garcia,yz and Mana M. Parast*y
ajp.amjpathol.orgFrom the Departments of Pathology* and Reproductive Medicine,z and the Sanford Consortium for Regenerative Medicine,y University of California San
Diego, La Jolla, California
CME Accreditation Statement: This activity (“ASIP 2014 AJP CME Program in Pathogenesis”) has been planned and implemented in accordance with the Essential Areas and
policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Society for Clinical Pathology (ASCP) and the
American Society for Investigative Pathology (ASIP). ASCP is accredited by the ACCME to provide continuing medical education for physicians.
The ASCP designates this journal-based CME activity (“ASIP 2014 AJP CME Program in Pathogenesis”) for a maximum of 48 AMA PRA Category 1 Credit(s). Physicians should
only claim credit commensurate with the extent of their participation in the activity.
CME Disclosures: The authors of this article and the planning committee members and staff have no relevant ﬁnancial relationships with commercial interests to disclose.Accepted for publicationC
P
hAugust 14, 2014.
Address correspondence to
Mana M. Parast, M.D., Ph.D.,
Sanford Consortium for
Regenerative Medicine,
Department of Pathology, Uni-
versity of California San Diego,
9500 Gilman Dr., MC 0695, La
Jolla, CA 92093. E-mail:
mparast@ucsd.edu.opyright ª 2014 American Society for Inve
ublished by Elsevier Inc. All rights reserved
ttp://dx.doi.org/10.1016/j.ajpath.2014.08.006Proper differentiation of placental epithelial cells, called trophoblast, is required for implantation. Early
during placentation, trophoblast cell columns help anchor the developing embryo in the uterine wall.
Although proximally continuous with villous cytotrophoblast (CTB) distally, these cells differentiate
into invasive extravillous trophoblast. We previously reported that p63, a p53 family member, is highly
expressed in proliferative villous CTB and required for induction of the trophoblast lineage in human
pluripotent stem cells. We now further explore its function in human trophoblast by using both primary
CTB from the early placenta and established trophoblast cell lines. We show that p63 is expressed in
epidermal growth factor receptor-positive CTB and that its expression decreases with differentiation
into HLA-Gþ extravillous trophoblast. In trophoblast cell lines, p63 is expressed in JEG3 cells but absent
from HTR8 cells. Overexpression of p63 in both cell lines enhances cell proliferation and signiﬁcantly
reduces cell migration; conversely, down-regulation of p63 in JEG3 cells reduces cell proliferation and
restores cell migration. Analysis of epithelial-to-mesenchymal transition, cell adhesion, and matrix
degradation pathways shows that p63 blocks epithelial-to-mesenchymal transition, promotes a CTB-
speciﬁc cell adhesion proﬁle, and inhibits expression of matrix metalloproteinases. Taken together,
these data show that p63 maintains the proliferative CTB state, at least partially through regulation of
epithelial-to-mesenchymal transition, cell adhesion, and matrix degradation pathways. (Am J Pathol
2014, 184: 3332e3343; http://dx.doi.org/10.1016/j.ajpath.2014.08.006)Supported by CIRM New Faculty Award RN2-00931-1 and NIH
National Institute of Child Health and Human Development grant
R01HD071100 (M.M.P.).
Y.L. and M.M.-Z. contributed equally to this work.
Disclosures: None declared.Proper fetal development in utero requires an appropriately
functioning placenta, able to deliver oxygen and nutrients to
the growing fetus. Functional epithelial cells of the placenta
are called trophoblast, which develop from the trophecto-
derm of the blastocyst.1,2 Early during human placental
development, proliferative cytotrophoblast (CTB) forms
cell columns, which help anchor the placenta to the uterus;
in the distal parts of such anchoring villi, the CTBs differ-
entiate into a migratory phenotype, the extravillous
trophoblast (EVT).1
EVT invades the uterus, establishing blood ﬂow to the
fetoplacental unit through remodeling of maternal spiralstigative Pathology.
.arterioles.1 The CTB-EVT differentiation is characterized by
an integrin switch, from a6b4 in the villous CTB to a5b1 in
the cell columns and a1b1 in the uterine wall.
3 Changes in
integrin expression are accompanied by changes in cell
adhesion properties and an increase in autophosphorylation
of focal adhesion kinase (FAK) in EVT.4
p63 Inhibits EVT MigrationMature EVTs are characterized by loss of expression of
epidermal growth factor receptor (EGFR) on their surface,
gaining instead surface expression of HLA-G and mela-
noma cell adhesion molecule.5e7 EVT differentiation also
resembles, in part, the process of epithelial-to-mesenchymal
transition (EMT), with reduction of E-cadherin expression
in the cell columns.8 Finally, EVT differentiation was also
compared with cancer cell invasion, because these cells
acquire the ability to secrete matrix metalloproteinases.9
Despite the above knowledge about markers of CTB and
EVT, little is known about transcription factors that regulate
each phenotype in the human placenta. We have previously
described expression of p63, a nuclear protein and tran-
scriptional regulator in the p53 family, in the human placenta
and have shown that it is expressed only in proliferative CTB
and completely excluded from both syncytiotrophoblast and
EVT.7 The a isoform of the N-terminally truncated p63
(DNp63a) has been shown to be involved in maintaining the
stem cell state in stratiﬁed epithelia, including skin.10,11 p63
is also known to regulate cell adhesion in mammary epithe-
lium, promoting adhesion-dependent protection against cell
death.12 In addition, both in bladder and prostate cancer cell
models, loss of DNp63a has been shown to promote EMT,
leading to greater invasive potential.13,14
We have recently determined that bone morphogenetic
protein-4einduced trophoblast differentiation of human
pluripotent stem cells occurs through a p63þ/KRT7þ inter-
mediate, likely representing a CTB stem cell state.15 We also
observed that forced expression of p63, speciﬁcallyDNp63a,
in cultured term CTB maintained cyclin B expression and
inhibited human chorionic gonadotropin (hCG) secretion.
Here, we dissect the role of p63 in more detail during the
CTB-to-EVT transition, evaluating changes in marker
expression and adhesive and migratory functions, using both
ﬁrst-trimester CTB and representative human trophoblast cell
lines.
Materials and Methods
Human Placental Samples and Isolation of Primary
Trophoblasts
Human placental tissues were collected under a protocol
approved by the Human Research Protections Program Com-
mittee of the University of California San Diego Institutional
ReviewBoard; all patients gave informed consent for collection
and use of these tissues. First-trimester trophoblasts were iso-
lated from placentas of 6 to 12 weeks’ gestation. Chorionic villi
were minced, washed in phosphate-buffered saline (PBS), and
subjected to three sequential digestions, digestion I: 300 U/mL
DNase I (Sigma-Aldrich, St. Louis, MO) and 0.125% trypsin
(Gibco, Carlsbad, CA); digestions II and III: 0.25% trypsin
(Gibco) and 300 U/mL DNase I. The pelleted cells from the
second and third digests were pooled, resuspended in Hanks’
balanced salt solution, and separated on a Percoll gradient. Cells
were plated onﬁbronectin-coated plates inDulbecco’smodiﬁedThe American Journal of Pathology - ajp.amjpathol.orgEagle’s medium/F12 with 10% fetal bovine serum (FBS), 1
penicillin/streptomycin, and 50 mg/mL gentamicin.
Cell Lines and Culture Conditions
The human choriocarcinoma cell line JEG3 was obtained from
theATCC (Manassas, VA). The human immortalized EVT cell
line HTR8 was a kind gift from Dr. Charles Graham (Queen’s
University, Kingston, ON, Canada). JEG3 cells were grown in
Dulbecco’s modiﬁed Eagle’s medium (Cellgro, MediaTech
Inc., Manassas, VA), supplemented with 10% FBS (Sigma-
Aldrich) and penicillin-streptomycin (Life Technologies,
Carlsbad, CA). HTR8 cells were grown in RPMI 1640medium
(Cellgro) also supplemented with 10% FBS and penicillin-
streptomycin (Gibco).
Flow Cytometric Analysis and FACS
Forﬂowcytometric analysis, cellswereﬁxed and permeabilized
with 100% ice-cold methanol for 30 minutes, then incubated
with primary antibodies on ice for 1 hour, followed by Alexa
Fluor 488-conjugated secondary antibodies (Invitrogen, Carls-
bad, CA) on ice for 1 hour. Cells were washed and resuspended
in 1 mL of ﬂuorescence-activated cell sorting (FACS) buffer
(0.5% bovine serum albumin and 1% FBS in PBS). Flow
cytometric analysis was performed with a BD FACS-Canto
Flow Cytometer (BD Biosciences, San Jose, CA). Primary
antibodies used forﬂow cytometry included rat antieE cadherin
(Abcam, Cambridge, MA), rat antieintegrin-b4 (Novus Bi-
ologicals, Littleton, CO), rabbit anti-EGFR (Santa Cruz
Biotechnology, Santa Cruz, CA). Alexa Fluor 488-conjugated
rat or rabbit IgG (Invitrogen) was used as isotype control.
For FACS of CTB, after isolation, the cells were washed
three times in PBS supplemented with 10% FBS. Cells were
then incubated in PBS plus serum at room temperature for 1
hour with an allophycocyanin antiehuman EGFR antibody
(clone AY13; BioLegend, San Diego, CA) and a phospha-
tidylethanolamine antiehuman HLA-G antibody (clone 87G;
BioLegend) followed by FACS with the use of a BD Inﬂux
cell sorter (BD Biosciences). The sorted cells were collected,
resuspended in RNA lysis buffer (mirVana miRNA Isolation
Kit; Ambion, Austin, TX), and stored at 80C until pro-
cessed for RNA extraction.
Immunostaining of Cells and Tissues
For immunoﬂuorescence staining, cells grown on coated
coverslips were ﬁxed with 4% paraformaldehyde in PBS at
room temperature for 10 minutes. Cells were then per-
meabilized with 0.3% Triton X-100 for 10 minutes and
incubated with primary antibodies, including rabbit antie
phospho-FAK (Y397; BD Biosciences) and mouse antieb-
catenin (BD Biosciences), and visualized by Alexa Fluor
488- or Alexa Fluor 595-conjugated secondary antibodies
(Invitrogen). For nuclear staining, cells were incubated with
DAPI (Invitrogen) for 5 minutes.3333
Table 1 List of Quantitative Real-Time PCR Primers
Primer name Primer sequence
TAp63
Forward 50-AAACAAGATTGAGATTAGCATGGA-30
Reverse 50-AGAGAGCATCGAAGGTGGAG-30
DNp63
Forward 50-CTGGAAAACAATGCCCAGA-30
Reverse 50-AGAGAGCATCGAAGGTGGAG-30
EGFR
Forward 50-CTAAGATCCCGTCCATCGCC-30
Reverse 50-GGAGCCCAGCACTTTGATCT-30
CDH1
Forward 50-CGAGAGCTACACGTTCACGG-30
Reverse 50-GGGTGTCGAGGGAAAAATAGG-30
SNAI1
Forward 50-TCGGAAGCCTAACTACAGCGA-30
Reverse 50-AGATGAGCATTGGCAGCGAG-30
CSH1/2
Forward 50-AATCCAATCTAGAGCTGCTCCGCA-30
Reverse 50-TGTCATACACCAGGTTGTTGGCGA-30
ERVW-1
Forward 50-GTCACTGTCTGTTGGACTTACT-30
Reverse 50-CGGCTGAGTTGGGAGATTAC-30
CGB
Forward 50-TGAGATCACTCACCGTGGTCTCC-30
Reverse 50-TTTATACCTCGGGGTTGTGGGG-30
ITGA6
Forward 50-GGCGGTGTTATGTCCTGAGTC-30
Reverse 50-AATCGCCCATCACAAAAGCTC-30
ITGA5
Forward 50-GGCTTCAACTTAGACGCGGAG-30
Reverse 50-TGGCTGGTATTAGCCTTGGGT-30
ITGB1
Forward 50-CCTACTTCTGCACGATGTGATG-30
Reverse 50-CCTTTGCTACGGTTGGTTACATT-30
ITGB4
Forward 50-CTCCACCGAGTCAGCCTTC-30
Reverse 50-CGGGTAGTCCTGTGTCCTGTA-30
MMP2
Forward 50-CCAAGGAGAGCTGCAACCTG-30
Reverse 50-TGGGCTTGCGAGGGAAGAAG-30
MMP3
Forward 50-CGGTTCCGCCTGTCTCAAG-30
Reverse 50-CGCCAAAAGTGCCTGTCTT-30
MMP9
Forward 50-AGACCTGGGCAGATTCCAAAC-30
Reverse 50-CGGCAAGTCTTCCGAGTAGT-30
MMP12
Forward 50-GGAATCCTAGCCCATGCTTTT-30
Reverse 50-CATTACGGCCTTTGGATCACT-30
18S
Forward 50-CGCCGCTAGAGGTGAAATTCT-30
Reverse 50-CGAACCTCCGACTTTCGTTCT-30
Li et alFor immunohistochemistry on formalin-ﬁxed, parafﬁn-
embedded human placenta tissue, serial sections were stained
with mouse anti-p63 (4A4 clone; Sigma-Aldrich), rabbit anti-
Ki67 (Abcam), mouse anti-CK7 (Abcam), or mouse antie
HLA-G (4H84 clone; Abcam), using a Ventana Discovery
Ultra automated immunostainer (Ventana Medical Systems,
Tucson, AZ) with standard antigen retrieval and reagents per
manufacturer’s protocol.
Cell Proliferation Assay
Cell proliferation was measured with the bromodeoxyur-
idine/7aminoactinomycin D (BrdU/7-AAD) Flow Kit (BD
Biosciences). Cells were labeled with 10 mmol/L BrdU for 30
minutes at 37C, then trypsinized and ﬁxed/permeabilized
with BD Cytoﬁx/Cytoperm buffer. Cells were treated with
DNase for 1 hour at 37C and stained with ﬂuorescein iso-
thiocyanateeconjugated anti-BrdU antibody. Total DNA
was determined by 7-AAD staining and analyzed by ﬂow
cytometry.
Quantitative Real-Time PCR
Total RNA was extracted with the mirVana RNA Isolation
Kit (Ambion) according to the manufacturer’s protocol.
Purity and concentration of the samples were assessed with
NanoDrop ND-1000 Spectrophotometer (Thermo Scientiﬁc
Inc., Waltham, MA). cDNA was prepared from 1 mg of
RNA by using iScript (Bio-Rad, Hercules, CA) in a 20-mL
reaction and diluted 1:5 with nuclease-free water. Quanti-
tative real-time PCR (qPCR) was performed with 4 mL of
the diluted cDNA, along with 625 nmol/L of each primer
and POWER SYBR Green PCR master mix (Applied Bio-
systems, Foster City, CA) in a total reaction volume of
20 mL. qPCR was performed with a System 7300 instrument
(Applied Biosystems) and a one-step program: 95C, 10
minutes; 95C, 30 seconds; 60C, 1 minute; for 40 cycles.
Unless otherwise stated, each experiment was performed in
triplicate, and all results were normalized against 18S
rRNA. Relative mRNA expression levels, compared with
18S rRNA, were determined by the DDCT method. All
primer pairs (Table 1) were checked for speciﬁcity by using
BLAST analysis and were checked by both agarose gel
electrophoresis and thermal dissociation curves to ensure
ampliﬁcation of a single product with the appropriate size
and melting temperature.
Standard RT-PCR for various TP63 isoforms was per-
formed with the indicated primers (Table 2).
p63 Lentiviral Constructs and Generation of Stable Cell
Lines
Full-length DNp63a cDNA was PCR-ampliﬁed and cloned
into pCMVelentiviral-based vector as previously described.15
pLKO.1-based scrambled and p63-speciﬁc shRNA lentiviral
constructs were obtained and used as previously described.153334Lentiviral supernatants were concentrated with PEG-it virus
precipitation solution (System Biosciences, Mountain View,
CA). The concentrated viral particles were then incubated with
target cells in the presence of 5 mg/mL polybrene (Sigma-
Aldrich). After 3 days of infection, cells were treated withajp.amjpathol.org - The American Journal of Pathology
Table 2 List of RT-PCR Primers Isoform-Speciﬁc Primers
Gene abbreviation Primer sequence
a Isoform
Forward 50-GAGGTTGGGCTGTTCATCAT-30
Reverse 50-AGGAGATGAGAAGGGGAGGAGA-30
b Isoform
Forward 50-GAGGTTGGGCTGTTCATCAT-30
Reverse 50-TCAGACTTGCCAGATCCTGACA-30
g Isoform
Forward 50-GAGGTTGGGCTGTTCATCAT-30
Reverse 50-GCTCCACAAGCTCATTCCTGAA-30
GAPDH
Forward 50-GAAGGTGAAGGTCGGAGTC-30
Reverse 50-GAAGATGGTGATGGGATTTC-30
p63 Inhibits EVT Migration5 mg/mL puromycin (Sigma-Aldrich) to select stably trans-
duced cells. Overexpression and knockdown efﬁciency were
determined by Western blot analysis.
Cell Migration Assay
Transwell membranes (8.0-mm pore inserts in 24-well Bio-
Coat Chambers; BD Biosciences) were used to study cell
migration in vitro. Cells were trypsinized, washed in cold
PBS, and resuspended in serum-free media with 5 104 cells
per well in the upper chamber and medium with 10% fetal
bovine serum in the lower chamber. After 16 to 24 hours of
incubation, cells on the upper surface were removed by
scrubbing with a cotton swab; ﬁlters were then stained with
Diff-Quik Stain Set (Dade Behring, Newark, DE). Three in-
dependent20ﬁelds for eachwellwere used for quantitation.
Cell Adhesion Assay
CyQUANT cell proliferation assay kit (Invitrogen) was used
to study cell adhesion. Two different densities of cells were
plated in a 96-well black plate (Greiner Bio-One, Long-
wood, FL). The cell suspensions were incubated at 37C for
1 hour to allow the cells to attach. The wells were then
washed three times gently with prewarmed PBS to remove
nonadherent cells. The ﬂuorescence of the samples was
measured by using a microplate reader at 480 nm/520 nm,
according to the manufacturer’s protocol.
hCG Hormone Secretion Assay
Cell culture supernatants were collected and stored at80C
until use. Levels of total hCG were quantiﬁed with the hCG
ELISA Kit (Calbiotech, Spring Valley, CA) according to the
manufacturer’s protocol. The results were normalized to
DNA content, quantiﬁed by DNeasy (Qiagen, Valencia, CA).
Western Blot Analysis
After washing with ice-cold PBS, cells were lyzed with
2 SDS-PAGE sample buffer (20 mmol/L Tris, pH 8.0, 2%
SDS, 2 mmol/L dithiothreitol, 1 mmol/L Na3VO4, 2 mmol/LThe American Journal of Pathology - ajp.amjpathol.orgethylenediamine tetraacetic acid, and 20% glycerol) and boiled
for 10 minutes. Protein concentration of each sample was
determined with a bicinchoninic acid protein assay reagent
(Thermo Scientiﬁc Inc.). Total cellular protein (30 mg) was
separated by 10% SDS-PAGE and then transferred to poly-
vinylidene diﬂuoride membranes. The membranes were
blocked for 1 hour at room temperature in 20 mmol/L Tris, pH
8.0, 150 mmol/L NaCl, and 0.05% Tween 20 (TBS-T) that
contained 5% nonfat dried milk. The membranes were then
incubated with the primary antibody overnight at 4C. Primary
antibodies includedmouse antieb-catenin (BD Biosciences),
mouse antieb-actin (Sigma-Aldrich), mouse anti-p63 (4A4
clone; Sigma-Aldrich), mouse antiephospho-FAK (Y397;
BD Biosciences), and mouse anti-total FAK (BD Bio-
sciences). After three washes in TBS-T, the membranes were
incubated with the appropriate horseradish peroxidasee
conjugated secondary antibodies (Jackson ImmunoResearch
Laboratories Inc., West Grove, PA) for 1 hour at room tem-
perature and then washed with TBS-T three times. The
labeled proteins were visualized with the enhanced chem-
iluminescence kit (Thermo Scientiﬁc Inc.).
Statistical Analysis
Unless otherwise stated, data presented are means  SD of
technical triplicates; the results shown are representative of
three to ﬁve separate experiments, each performed with a
different preparation of cells. Student’s t-test was performed,
and P < 0.05 was considered statistically signiﬁcant.
Results
Localization of p63 in the Early Placenta Tissue
Previously, we have shown that, in placentas across gesta-
tion, p63 is expressed in all Ki-67þ villous CTBs but is not
expressed in villous syncytiotrophoblast and invasive
EVT.7 To expand on this ﬁnding, we ﬁrst performed
immunohistochemistry on the earliest human placental tis-
sue we had, a blastocyst 16 days after implantation seren-
dipitously discovered in an archived hysterectomy specimen
in which the indication for the procedure was uterine pro-
lapse (Figure 1A). We conﬁrmed that the majority of p63
staining was localized to the villous CTB layer, immediately
adjacent to the villous stroma. p63 was absent from the
syncytiotrophoblast. In addition, although rare proximal cell
column trophoblasts were p63þ, the distal column and
invasive EVT at the implantation site were p63. All p63þ
cells were also Ki-67 positive, although the Ki-67þ cells
located in the distal cell column were in fact negative for
p63. HLA-G stained a subset of EVT in the distal cell col-
umn and invasive EVT at the implantation site. Finally, p63
staining overlapped with p57 only in CTB (rare ones in the
embryo and almost all CTBs in later ﬁrst-trimester tissue),
whereas the p57þ cell column and mature EVT were
negative for p63 (Figure 1B).3335
Figure 1 Marker expression in early placental tissue and isolated primary cytotrophoblast (CTB). A: Human placenta at 4 weeks’ gestational age shows p63
staining localized exclusively to the villous CTB layer and HLA-G staining in the distal cell column and invasive extravillous trophoblast (EVT) at the implantation
site. p57 staining is seen in rare villous CTB, villous mesenchymal cells, and distal cell column and invasive EVT. Note that all p63þ cells are also Ki-67þ; Ki-67þ
trophoblast extends well into the cell column. B: p63 and p57 overlap signiﬁcantly more in the CTB of a human placenta at later gestation (8 weeks). C: Real-time
quantitative PCR of CTB- and EVT-speciﬁc genes in primary CTB and EVT cells isolated from placentas at 6 to 8 weeks’ gestation. Data are normalized to 18S. Data
are expressed as fold change relative to CTB; error bars indicate SD of technical triplicates. *P < 0.05 in comparison with CTB values.
Li et al
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Figure 2 p63 promotes proliferation in the HTR8 EVT cell line. A: Conﬁr-
mation of p63 overexpression by Western blot analysis, compared with endog-
enous levels in two different preparations of ﬁrst-trimester CTB. b-actin served
as loading control. B: Cell proliferation assay with BrdU/7-AAD double staining,
followed by ﬂow cytometric analysis. p63-overexpressing cells show a higher
percentage of cells in S-phase (P2 region) compared with cells transduced with
an empty lentivirus. Data are expressed as means SD of triplicate cell samples
(B).nZ3 independentexperiments (B). *P<0.05 in comparison tomock cells.
p63 Inhibits EVT MigrationTo conﬁrm these in vivo data, we isolated CTB from pla-
centas at 6 to 8 weeks of gestation and fractionated them into
villous CTB and EVT by FACS, based on surface expression
of EGFR and HLA-G, respectively. RNA was isolated from
both cell fractions and qPCRwas performed (Figure 1C). The
results suggested the EGFRþ CTB fraction was highly
enriched in p63, EGFR, CDH1, ITGA6, and ITGB4, whereas
the EVT fraction was highly enriched in HLA-G, SNAI1,
ITGA5, and multiple matrix metalloproteinases (MMP)-2,
-3, -9, and -12.
It has been shown that p63 has six isoforms that are
expressed in a tissue-speciﬁc manner.16 On the basis of our
previous study, DNp63a was the most abundant isoform in
CTBs isolated from term human placental tissues.15 To
determine which p63 isoform(s) is (are) expressed in ﬁrst-
trimester CTB, we ﬁrst performed qPCR with TAp63- and
DNp63-speciﬁc primers and found DNp63 to be the major
isoform. With the use of C-terminalespeciﬁc primers in a
standard real-time PCR, we found the a isoform to be the
main isoform, with only a minute amount of the b and g
isoforms also detected (Supplemental Figure S1).
p63 Promotes Trophoblast Cell Proliferation
Primary isolated CTB quickly lose their proliferative po-
tential in vitro. Therefore, to assess the role of p63 in human
trophoblast proliferation, we turned to available cell lines for
modeling EVT differentiation: JEG3 and HTR8 cells. Of
these, only JEG3 cells expressed p63. We checked p63
isoform expression in JEG3 cells and conﬁrmed that, similar
to ﬁrst-trimester CTB, JEG3 cells mainly express DNp63a
(Supplemental Figure S1).
We generated a lentiviral expression construct with
DNp63a downstream of the cytomegalovirus promoter. First,
we infected the HTR8 cell line, an immortalized EVT cell line,
with undetectable levels of endogenous p63. We conﬁrmed
p63 overexpression byWestern blot analysis; comparisonwith
primary CTB found higher p63 protein levels in the HTR8
cells that overexpressed p63 (Figure 2A). Then we checked
cell proliferation with BrdU/7-AAD double staining by ﬂow
cytometry. p63-overexpressing HTR8 cells indicated a higher
percentage of cells in S-phase compared with control mock-
infected cells (Figure 2B).
Because HTR8 cells did not have endogenous p63, we also
used JEG3 cells, ﬁrst to conﬁrm the effects of p63 over-
expression, and then proceeded to p63 knockdown experi-
ments. We used the same construct as above to overexpress
DNp63a and previously generated shRNA-lentiviral cocktail
to knockdown its expression in JEG3 cells.15 We conﬁrmed
overexpression and knockdown by Western blot analysis
(Figure 3A). Similar to HTR8 cells, JEG3 cells over-
expressing p63 indicated an increase in proportion of cells in
S-phase, compared with control mock-infected cells.
Conversely, this population was reduced in p63-knockdown
cells, indicating a clear role for p63 in regulation of tropho-
blast proliferation (Figure 3B).The American Journal of Pathology - ajp.amjpathol.orgp63 Maintains the CTB Phenotype of Both Human
Trophoblast Cell Lines and Primary CTB
Next, we performed functional analysis of trophoblast dif-
ferentiation in comparison with changes in gene expression
after manipulation of p63 expression. We assessed cell
migration, a characteristic feature of EVT, in both JEG3 and
HTR8 cell lines; we also assessed hormone (hCG) secretion,
a characteristic feature of syncytiotrophoblast, which also
occurred in JEG3 cells. p63-overexpressing HTR8 cells
exhibited reduced cell migration compared with control cells
in the Transwell migration assay (Figure 4A). These cells also
up-regulated expression of EGFR and ITGB4 and down-
regulated expression of ITGB1, SNAI1, MMP-2, and
MMP-3 (Figure 4B). Although CDH1 mRNA remained un-
changed (data not shown), expression of EGFR, CDH1, and
ITGB4 increased according to ﬂow cytometric analysis in
p63-overexpressing HTR8 cells (Figure 4C). Immunostain-
ing conﬁrmed EGFR expression to be enhanced, particularly
in p63high HTR8 cells (Figure 4D).
In JEG3 cells, overexpressing p63 also inhibited cell
migration; however, cells with p63 knockdown did not3337
Figure 3 p63 promotes proliferation of JEG3
choriocarcinoma cells. A: Conﬁrmation of p63 over-
expression and knockdown by Western blot analysis.
b-Actin served as loading control. B: Cell prolifera-
tion assay with BrdU/7-AAD double staining by ﬂow
cytometric analysis. p63-overexpressing cells show a
higher percentage of cells in S-phase and lower
percentage of cells in G0/G1 phase compared with
control cells. Conversely, p63-knockdown cells show
a lower percentage of cells in S-phase and higher
percentage of cells in G0/G1 phase compared with
scramble control cells. Data are expressed as
means SD of triplicate cell samples (B). *P< 0.05
in comparison with mock-infected or scramble
shRNA-infected values.
Li et alshow a further elevation in migration (Figure 5A). In terms
of hormone production, JEG3 cells overexpressing p63 had
decreased hCG secretion, whereas cells with p63 knock-
down indicated a small, albeit statistically signiﬁcant, in-
crease in hormone secretion compared with the scrambled
control (Figure 5B). Gene expression changes in
p63-overexpressing JEG3 cells were consistent with inhi-
bition of terminal differentiation, showing a reduction in
SNAI1, ERVW-1 (syncytin), CGB, and CSH1 (Figure 5C).
Gene expression changes in p63-knockdown JEG3 cells
were more modest, showing statistically signiﬁcant in-
creases only in CGB and CSH1 (Figure 5C).
Finally, in primary ﬁrst-trimester CTB, we tested the ef-
fect of p63 overexpression, because these cells rapidly lost
p63 after plating. Infection with a green ﬂuorescent pro-
teineexpressing lentivirus conﬁrmed maximal gene
expression at day 4 after infection (Figure 6A). p63-
overexpressing CTB did not show altered expression of
EGFR or HLA-G by ﬂow cytometry or hCG secretion by
ELISA (data not shown). However, qPCR found signiﬁ-
cantly decreased expression of EVT markers, including
MMP-2, -3, and -12 and ITGA1, ITGA5, and ITGB1
(Figure 6B) at day 6 after infection.
p63 Promotes a CTB-Like Cell Adhesion Proﬁle
Because CTB differentiated into EVT during early placental
development, they decrease cell-cell adhesion and instead
develop stronger cell-matrix adhesive properties, with3338greater focal adhesion turnover required for cell migration.
To determine whether the effect of p63 on trophoblast
migration may be mediated through changes in adhesive
properties, we evaluated cell adhesion in HTR8 cells. We
measured cell adhesion 1 hour after plating HTR8 cells,
with or without p63 expression, at two different densities.
We found that overexpression of p63 decreases cell adhe-
sion to tissue culture plastic in a cell density-independent
manner (Figure 7A). We next evaluated focal adhesion size
and turnover, using phosphorylated FAK (pY397FAK).
Immunocytochemical staining found smaller, more pe-
ripheral focal adhesion sites in p63-overexpressing cells,
compared with the larger, more central focal adhesions in
the control cells (Figure 7B). Western blot analysis
conﬁrmed this phenotype, showing FAK phosphorylation
to be lower at the basal state and increasing more slowly
after adhesion in p63-overexpressing cells compared with
control cells (Figure 7C). Conversely, b-catenin expression
was higher in p63-overexpressing cells (Figure 7C), local-
izing in abundance in cell-cell junctions (Figure 7D). These
data indicate that p63 alters both cell migration and cell
adhesion during trophoblast differentiation.Discussion
Proper differentiation and function of EVT are crucial to
pregnancy success, because these cells are responsible for
establishing the maternal-fetal interface early on afterajp.amjpathol.org - The American Journal of Pathology
Figure 4 p63overexpression shifts theEVT cell line,HTR8, towardaCTBphenotype.A: Transwellmigrationassayof p63-overexpressingHTR8andmock control (empty
lentivirus-transduced) cells.B:Real-timequantitativePCR for p63, EGFR, ITGB1, ITGB4, SNAI1, andMMP-2, -3, and -9 inp63-overexpressingHTR8cells.Dataarenormalized
to 18S. C: Surface expression of EGFR, CDH1, and ITGB4 in mock (red) and p63-overexpressing (blue) cells by ﬂow cytometric analysis. D: HTR8 cells, infected with either
empty or p63-expressing lentivirus, are immunostained for p63 (red) and EGFR (green), with numerous cells showing costaining. Data are expressed as means  SD of
triplicateﬁlters (A); fold change relative to themock cells of technical triplicates (B).nZ3 independent20ﬁelds foreachwell (A). *P<0.05 incomparison tomockcells.
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Figure 5 p63 maintains the CTB phenotype of human trophoblast cell line, JEG3. A: Transwell migration assay of mock, p63-overexpressing, scramble
control, and p63-shRNA JEG3 cells. B: hCG ELISA of mock, p63-overexpressing, scramble control, and p63 shRNA JEG3 cells; hCG secretion was normalized to
DNA content. C: Gene expression changes in p63-overexpressing and -knockdown JEG3 cells by real-time quantitative PCR. Data are expressed as means  SD
of triplicate ﬁlters (A); of technical triplicates (B and C). nZ 3 20 ﬁelds for each well (A). *P < 0.05 in comparison with mock-infected or scramble shRNA-
infected values.
Li et alimplantation.1 In this study, we have determined a role for
p63, speciﬁcally DNp63a, in maintaining cells in a CTB
stem cell-like state, based on both gene expression and
functional evaluation.
Both immunohistochemistry and qPCR found that p63
expression is lost quickly on differentiation into the EVT
lineage. Few other transcription factors show such a dramatic
down-regulation going from villous stroma-adjacent CTB into
the cell column. ID-2 has perhaps themost similar localization,
but it is still expressed in the proximal column trophoblast,
slightly removed from the villous stroma.17 Although p63
expression was not found in all proliferative trophoblast in the
early human placenta, all p63þCTBswereKi-67þ; in fact, p63
overexpression promoted the G1- to S-phase transition in both
human trophoblast cell lines tested. This is consistent with
our previous data, showing that forced expression of p63 in
term CTB inhibits hCG secretion and maintains cyclin B1
expression15; the latter has also been noted with ID-2 over-
expression,17 and, at least in this respect, these two proteins
appear to be functionally equivalent. Subsequent analysis,
however, found that p63 function diverges from ID-2, partic-
ularly in terms of its effects on cell migration.
In fact, overexpression of DNp63a had multiple
differentiation-inhibitory effects, decreasing migration in3340both cell lines and hCG secretion in JEG3 cells. Gene
expression changes were consistent with this phenotype,
showing that p63 increased markers associated with CTB,
including EGFR and ITGB4, and decreased markers asso-
ciated with EVT, including SNAI1, ITGB1, and several
MMPs. Because MMPs are responsible for matrix remod-
eling,9 it is likely that modulation of their expression
contributed, at least in part, to the p63-overexpression
phenotype of blunted migration. Knockdown of p63 in
JEG3 cells had a signiﬁcantly milder phenotype but was
nevertheless consistent with a role for p63 in maintaining
the CTB state, with a slight increase in hCG secretion and
associated gene expression changes. The rather mild
knockdown phenotype can be attributed to a relatively low
basal expression of p63 protein in JEG3 cells; however, it is
also possible that p63 knockdown alone is not sufﬁcient to
induce trophoblast differentiation.
p63 overexpression in the primary CTB also interfered
with EVT-associated gene expression, although the cells
did not have signiﬁcantly different surface expression of
HLA-G or hCG secretion. This may have been partly due to
the delayed expression of the transgene not being uniformly
expressed until 3 days after infection (Figure 6A), leading to
initiation of differentiation before signiﬁcant transgeneajp.amjpathol.org - The American Journal of Pathology
Figure 6 p63 overexpression in primary ﬁrst-trimester CTB. A: Infection of primary CTB with a green ﬂuorescent proteineexpressing lentivirus; note that
transgene expression is sparse before day 3 and decreases after day 4. B: Real-time quantitative PCR for p63, MMP-2, -3, -12, integrin beta (ITGA)1, ITGA5, and
ITGB1 in p63-overexpressing cells. Data are normalized to 18S. Data are expressed as fold change, relative to the mock cells on day 4, as means  SD of
technical triplicates (B). *P < 0.05 in comparison to mock cells of the same day.
p63 Inhibits EVT Migrationexpression. This is supported by the fact that most decreases
in EVT-associated gene expression were not seen until day
6 after infection (Figure 6B).
How p63 functions to maintain the CTB stem cell state is
likely to be complex. p63 is a nuclear protein and transcription
factor, known to have numerous target genes according to data
from chromatin immunoprecipitation and knockout mouseThe American Journal of Pathology - ajp.amjpathol.orgmodels.18 Interestingly, some of the target genes, speciﬁcally
of DNp63a, include CTB-associated markers EGFR and
integrin b4 and b-catenin,18 some of the genes which we noted
to be up-regulated in DNp63a-overexpressing HTR8 cells.
DNp63a is thought to regulate cell adhesion through modu-
lation of some of the same genes.12 However, although
overexpression of DNp63a induces FAK phosphorylation3341
Figure 7 p63 regulates cell adhesion properties. A: p63-overexpressing cells show decreased adhesion to tissue culture plastic 1 hour after plating. B:
Immunocytochemical staining of pY397FAK. p63-overexpressing cells show more peripheral focal adhesions compared with the larger, more central focal
adhesions in the mock control cells. C: Western blot analysis of pY397FAK, total FAK, and b-catenin at 0, 1, 8, and 24 hours after plating. Numbers below each
blot reﬂect the amount of pY397FAK (normalized to total FAK) and b-catenin (normalized to b-actin), relative to mock cells at time 0. FAK phosphorylation is
lower at the basal state and increases more slowly after plating in p63-overexpressing cells compared with mock control cells. b-catenin expression was higher
in p63-overexpressing cells. b-actin served as loading control. D: Immunocytochemical staining of b-catenin. p63-overexpressing cells show more b-catenin in
their cell-cell junctions compared with mock cells. Data are expressed as means  SD of triplicate wells (A). *P < 0.05 in comparison with mock-infected cells.
Li et alin primary mammary epithelial cells,12 we noted lower
basal levels and a slower induction of phosphorylated FAK
in p63-overexpressing HTR8 cells after plating, although at
later time points FAK phosphorylation appeared to catch up
(Figure 7C). Our data are consistent with in vivo levels of
pY397FAK in the placenta, with higher levels noted in
invasive EVT.4 These data are signiﬁcant because FAK
phosphorylation/activity is required for focal adhesion
turnover and cell migration.19 However, the change in
FAK phosphorylation, in and of itself, is likely too small
to account for the reduced migratory ability of p63-
overexpressing cells. Rather, other changes, including
reduced expression of MMPs after p63 overexpression,
likely contribute to this phenotype.
Finally, p63 is known to regulate EMT, a process that has
been studied in most detail in the context of metastasis. p63
targets include E-cadherin itself12 and multiple ligands,
receptors, and effectors of transforming growth factor-b/bone
morphogenic protein signaling, a crucial regulator of EMT.18
In addition, a recent study in bladder cancer reported a role
for miRNA miR-205 downstream of inhibition of EMT by
DNp63a.14 In the context of the placenta, EMT remains3342somewhat controversial20,21; for example, although E-cad-
herin expression has been shown to be reduced in the cell
column,8 Floridon et al22 have noted E-cadherin to be
re-expressed in a subpopulation of invasive EVT. Never-
theless, the loss of apico-basal polarity and gain of migratory
and invasive potential during CTB-to-EVT differentiation
are consistent with the general concept of EMT. Consistent
with inhibition of EMT, we found a reduction in SNAI1
expression in both HTR8 and JEG3 cells overexpressing
DNp63a; however, the reciprocal increase in E-cadherin
expression was only noted at the level of protein. Neverthe-
less, functional data, including the decrease in migratory
ability in DNp63a-overexpressing cells, were also consistent
with inhibition of EMT.Conclusion
Our data indicate a speciﬁc role for DNp63a, the main
isoform of p63 in the human placenta, in inhibition of EVT
migration and maintenance of the undifferentiated state in
CTB. Although the direct targets of DNp63a in these cellsajp.amjpathol.org - The American Journal of Pathology
p63 Inhibits EVT Migrationremain to be further evaluated, changes in cell adhesion
properties, accompanied by speciﬁc alterations in both gene
expression and post-translational modiﬁcation of adhesion-
related proteins, at least partly explain its mechanism of
action in maintaining the CTB stem cell state.Acknowledgments
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